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We previously identified a gene cluster, epa (for enterocococcal polysaccharide antigen), involved in poly-
saccharide biosynthesis of Enterococcus faecalis and showed that disruption of epaB and epaE resulted in
attenuation in translocation, biofilm formation, resistance to polymorphonuclear leukocyte (PMN) killing, and
virulence in a mouse peritonitis model. Using five additional mutant disruptions in the 26-kb region between
orfde2 and OG1RF_0163, we defined the epa locus as the area from epaA to epaR. Disruption of epaA, epaM, and
epaN, like prior disruption of epaB and epaE, resulted in alteration in Epa polysaccharide content, more round
cells versus oval cells with OG1RF, decreased biofilm formation, attenuation in a mouse peritonitis model, and
resistance to lysis by the phage NPV-1 (known to lyse OG1RF), while mutants disrupted in orfde2 and
OG1RF_163 (the epa locus flanking genes) behaved like OG1RF in those assays. Analysis of the purified Epa
polysaccharide from OG1RF revealed the presence of rhamnose, glucose, galactose, GalNAc, and GlcNAc in
this polysaccharide, while carbohydrate preparation from the epaB mutant did not contain rhamnose, sug-
gesting that one or more of the glycosyl transferases encoded by the epaBCD operon are necessary to transfer
rhamnose to the polysaccharide. In conclusion, the epa genes, uniformly present in E. faecalis strains and
involved in biosynthesis of polysaccharide in OG1RF, are also important for OG1RF shape determination,
biofilm formation, and NPV-1 replication/lysis, as well as for E. faecalis virulence in a mouse peritonitis model.
Enterococci are among the major causes of endocarditis and
nosocomial infections, with Enterococcus faecalis the most
commonly identified species (7, 22). The antibiotic resistance
of enterococci not only causes difficulty in treatment of entero-
coccal infections but also appears to promote their survival in
hospitalized, antibiotic-exposed individuals, helping to explain
their important role in the nosocomial milieu.
In order to understand the mechanisms of enterococcal
pathogenesis, which may lead to development of alternative
approaches to prevent and/or treat enterococcal infections, we
and other investigators have identified several enterococcal
factors important for virulence, including proteins and poly-
saccharides (11). Polysaccharides are composed of repeating
units of oligosaccharides, are important components of bacte-
rial cell walls, and can be associated with bacterial surfaces
through linkage to the cell membrane, peptidoglycan, or by
other unknown mechanisms. Polysaccharides also play impor-
tant roles in bacterial pathogenesis. They have been shown to
be important for adherence to and invasion of host tissues (10,
19), for resistance to host defense systems such as phagocytosis
(1, 2, 8, 12, 24, 30), and for induction of host inflammatory
responses (14, 25). Vaccine potential of surface polysaccha-
rides has been shown for different bacteria, such as pneumo-
cocci (20), and antibodies against capsular carbohydrates have
been shown to promote polymorphonuclear leukocyte (PMN)-
mediated killing of E. faecalis and Enterococcus faecium and to
protect mice against E. faecalis infection (16–18, 24). These
capsular carbohydrates of E. faecalis have been shown to be
type specific, and the type-specific genes are present only in
some populations of enterococci (16–18).
We previously identified an Escherichia coli recombinant
clone, TX5159, containing 43-kb cloned DNA from E. faecalis
OG1RF, that reacted with sera from four patients with E.
faecalis endocarditis but not with rabbit serum raised against
surface protein extracts of E. faecalis (31, 32). Sequence anal-
ysis of the clone revealed similarity to genes involved in poly-
saccharide biosynthesis in other organisms, and the ladder-like
material expressed in E. coli was sensitive to periodate but
resistant to proteinase K treatment, indicating that these genes
are involved in polysaccharide biosynthesis (32). The genes
identified in this clone were named “orfde1” through “orfde16”
(Table 1), and the gene cluster was named “epa” (for entero-
coccal polysaccharide antigen) (32). Although the start and the
end of the epa gene cluster were not determined in E. faecalis,
our previous sequence analysis of the cosmid clone revealed
putative promoters upstream of orfde1, -2, -3, -4, -5-6, -6, -11,
and -16 and our data with reverse transcription-PCR (RT-
PCR) and transposon insertions in the E. coli clone indicated
that orfde6 (epaE) was cotranscribed with orfde7 to -10 but was
transcribed independently from the upstream gene, orfde4
(epaB), and from the downstream gene, orfde11 (epaL) (32,
33). Our previous results also suggested that orfde4 (epaB) and
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orfde6 (epaE), but not orfde1 and orfde2, are required for
polysaccharide biosynthesis (32) and comparison of the orfde4
(epaB) and orfde6 (epaE) disruption mutants with wild-type
OG1RF showed that these mutants are deficient in transloca-
tion across polarized human enterocyte-like T84 cells (34) and
biofilm formation (21), are more susceptible to PMN-mediated
killing (26), and are attenuated in a mouse peritonitis model
(33). The role of the other genes in polysaccharide biosynthesis
has not been previously analyzed. We have also observed that
antibody (using patient serum) eluted from the polysaccharide
material produced by the E. coli clone did not react with an E.
faecalis OG1RF extract in Western blots (33). However, use of
whole serum from the same patient detected polysaccharides
(by Western blots) in E. faecalis OG1RF but not in the orfde4
(epaB) and orfde6 (epaE) disruption mutants (26), suggesting
that the polysaccharide expressed by OG1RF may be different
structurally from that expressed by the E. coli clone TX5159
containing the OG1RF epa genes. The structure and location
of Epa have not been reported, although other investigators
have suggested that Epa may be buried inside the cell wall (13).
In the present study, we examined the limits of the epa gene
cluster in OG1RF, the composition of Epa polysaccharides,
and some of the functions associated with the polysaccharide
gene cluster.
MATERIALS AND METHODS
Bacterial strains and media. The bacterial strains used in the study are listed
in Table 2. The epaB (formerly, orfde4) and epaE (formerly, orfde6) disruption
TABLE 1. Annotation of cosmid, OG1RF ID, and V583 ID
Prior cosmid gene namea OG1RF ID V583 ID % Similarityb Definition
orfde1 orfde1 EF2200 100 Methionine aminopeptidase
orfde2 orfde2 EF2199 100 Probable RNase BN
orfde3 epaA EF2198 100 Glycosyl transferase, group 4 family protein
orfde4 epaB EF2197 100 Glycosyl transferase, group 2 family protein
orfde5 epaC EF2196 98 Glycosyl transferase, group 2 family protein
orfde5-6 epaD EF2195 100 Glycosyl transferase, group 2 family protein
orfde6 epaE EF2194 100 Glucose-1-phosphate thymidylyltransferase
orfde7 epaF EF2193 100 dTDP-4-dehydrorhamnose 3,5-epimerase
orfde8 epaG EF2192 99 dTDP-glucose 4,6-dehydratase
orfde9 epaH EF2191 99 dTDP-4-dehydrorhamnose reductase
orfde10 epaI EF2190 99 Glycosyl transferase, group 2 family protein
Not identified epaJ EF2189 97 Hypothetical membrane protein
Not identified epaK EF2184 100 Hypothetical membrane protein
orfde11 epaL EF2183 100 ABC transporter, permease protein
orfde12 epaMd EF2182 100 ABC transporter, ATP-binding protein
orfde13
orfde14 epaNe EF2181 99 Glycosyl transferase, group 2 family protein
orfde15
orfde16 epaO EF2180 99 Glycosyl transferase, group 2 family protein
epaP EF2179 100 Hypothetical membrane protein
epaQ EF2178 99 Hypothetical membrane protein
epaR EF2177 100 Sugar transferase
OG1RF_0164c EF2176 Glycosyl transferase, group 2 family protein
EF2175f LicD-related protein
OG1RF_0163 EF2174 81 Glycosyl transferase, group 25 family protein
a As designated by Xu et al. (31, 32).
b Percentage of similarity between OG1RF and its homologue in V583.
c As designated by Bourgogne et al. (4).
d orfde12 and orfde13 form the upstream and downstream portions of epaM.
e orfde14 and orfde15 form the upstream and downstream portions of epaN.
f EF2175 is a pseudogene in OG1RF.
TABLE 2. Strains used in this study
Strain (alternative name) Characteristicsa Source orreference
OG1RF (TX4002) Well-characterized E. faecalis strain; Fusr Rifr 23
TX10113 orfde2 (EF2199) disruption mutant, disruption starts at bp 616 of the 908-bp orfde2 gene; Kanr-src This study
TX10114 epaA (formerly orfde3) disruption mutant, disruption starts at bp 1111 of the 1,136-bp epaA gene; Kanr This study
TX5179 epaB (formerly orfde4) disruption mutant, disruption starts at bp 243 of the 788-bp epaB gene; Kanr 33
TX5180 epaE (formerly orfde6) disruption mutant, disruption starts at bp 252 of the 866-bp epaE gene; Kanr 33
TX5391 epaM disruption mutant, disruption starts at bp 1,000 of the 1,217-bp epaM gene; Kanr This study
TX5436 epaN disruption mutant, disruption starts at bp 2222 of the 3,143-bp epaN gene; Kanr This study
TX5179.1 epaB-complemented strain, in which the plasmid contains 3,198 bp that includes epaB, epaC, and 682/
713 bp of epaD; Eryr Kanr
34
DAGF29 Tn917 transposon insertion at bp 1245 from the OG1RF_0163/EF2174 ATG in OG1RF; Eryr 9
a Chl, chloramphenicol; Ery, erythromycin; Fus, fusidic acid; Kan, kanamycin; Rif, rifampin.
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mutants TX5179 and TX5180, as well as the epaBCD-complemented strain
TX5179.1, were constructed previously (33, 34). Cosmid, OG1RF, and V583
identification (ID) tags are shown in Table 1. A transposon insertion mutant in
the OG1RF homologue of EF2174 (OG1RF_0163) (4) was kindly provided by
Danielle Garsin (9). Escherichia coli strains were grown in LB medium (Difco
Laboratories, Detroit, MI) with appropriate antibiotics, while E. faecalis strains
were grown routinely in brain heart infusion (BHI) (Difco) or Todd Hewitt (TH)
(Difco) medium with appropriate antibiotics, unless otherwise indicated.
Construction of disruption mutants, growth, stability, and morphology assays.
The orfde2, epaA, epaM, and epaN disruption mutants of E. faecalis OG1RF were
constructed using intragenic fragments (primers are listed in Table S1 in the
supplemental material) and the suicide vector pTEX4577 by methods described
previously (28). Briefly, an internal fragment was amplified from OG1RF
genomic DNA and cloned into the TOPO TA cloning vector (Invitrogen, Carls-
bad, CA). The fragments were then released from the vector by EcoRI and
cloned into pTEX4577. The resulting constructs were electroporated into E.
faecalis OG1RF, and the mutants were selected with 2,000 g of kanamycin per
ml. Growth of wild-type OG1RF and the mutants was examined by growth in
BHI, in Trypticase soy broth (Difco) with 0.25% glucose (TSBG; medium used
for biofilm), and in BHI plus 40% horse serum (BHIS) and measurement of the
optical density at 600 nm (OD600) at different time points up to 14 h. CFU were
determined at 0, 3, 6, and 24 h on BHI agar. Stability of the mutants was
examined by growth in BHI broth without antibiotics for 24 h and counting the
number of CFU on BHI and BHI-kanamycin (2,000 g/ml) plates. Bacterial
morphology after 24 h of growth in BHI, BHIS, TSBG, and in TH  1% glucose
was observed under a phase-contrast microscope. Statistical analysis was per-
formed using a nonparametric t test and analysis of variance for multiple com-
parisons.
qRT-PCR. RNA was extracted using RNAwiz (Ambion, Austin, TX) from
cells collected at the late log growth phase from BHI broth as described previ-
ously (5). Five micrograms of RNA was treated twice with DNA-free (Ambion,
Austin, TX) according to the supplier’s protocol. Quantitative RT-PCR (qRT-
PCR) on cDNA was performed using SYBR green (Applied Biosystems, Foster
City, CA) and an XFRTG cycler (Applied Biosystems) as previously published
(6). The primers are listed in Table S1 in the supplemental material, and their
location is illustrated by an asterisk in Fig. 1B. The amount of transcript obtained
for each of the primer sets was normalized with the amount of gyrB transcripts.
Statistical analysis was performed using a nonparametric t test.
Extraction of crude carbohydrates from E. faecalis and analysis. E. faecalis
OG1RF and its derivatives were inoculated into 200 ml of TH broth with 1.0%
glucose and grown without shaking for 24 h at 37°C. Cells were harvested and
resuspended in 1.5 ml phosphate-buffered saline (PBS), followed by addition of
100 l of mutanolysin (5 U/l) and 250 l of lysozyme (40 mg/ml). After 1 h of
incubation at 37°C, 20 l of MgSO4 (1 M), 4 l of CaCl2 (0.5 M), 20 l of RNase
(10 mg/ml), and 20 l of DNase I (10 mg/ml) were added and the mixture was
incubated for an additional 2 h at 37°C, followed by addition of 40 l of
proteinase K (25 mg/ml) and overnight incubation at 56°C. All enzymes were
obtained from Sigma (St. Louis, MO). Cell debris was removed by centrifugation,
supernatant was recovered and extracted with CIP (chloroform-isoamyl alcohol-
phenol at 24:1:25 [vol/vol/vol]), and polysaccharides were precipitated by ethanol
(final concentration, 80%). After centrifugation, the pellet was washed with 75%
ethanol, air-dried, and dissolved in 200 l of distilled water (dH2O). To separate
FIG. 1. OG1RF and its derivatives. (A) Illustration of the epa gene cluster. In white are the genes belonging to the epa locus. (B) Disruptions
in orfde2, epaA, epaB, epaE, epaM, and epaN (using pTEX4577) are denoted by an inverted triangle, while disruption of OG1RF_163 was made
using Tn917. The name of the strain is in boldface, and the disrupted gene is indicated in parentheses. The arrows above the genes represent the
transcripts determined by qRT-PCR. The asterisks indicate the locations of the qRT-PCR primers for each gene. (C) Growth curve of OG1RF
and its derivatives in TSBG (biofilm medium). (D) Growth curve of OG1RF and its derivatives in BHIS. These experiments (C and D) were
performed at least twice, and results from one representative experiment are shown.
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polysaccharides, 10-l samples were run on a 0.8% agarose gel and stained with
Stains-All (Sigma) overnight in the dark and destained with light. A Western blot
was performed as described previously (31).
Purification and compositional analysis of polysaccharides. A crude extract of
carbohydrates prepared (as described above) from 20 liters of E. faecalis OG1RF
was used for column purification. The crude extract (about 15 ml) was first
purified using BioGel P-100 (Bio-Rad, Hercules, CA) and 3 bed volumes of 50
mM Tris-HCl (pH 8.0). The collected fractions were assayed by a colorimetric
method for carbohydrate quantification. Briefly, 60 l of sample was added into
a well of a 96-well microtiter plate, followed by addition of 30 l of 5% phenol
and 140 l of 95.5% H2SO4. The plate was incubated at room temperature for
20 min, and the OD490 was measured. The approximate amount of carbohydrates
in a sample was calculated by comparing the OD490 of the sample versus that of
a series of glucose standards (10, 5, 2.5, 1.25, and 0.625 mg/ml). The fractions
were pooled and further purified using the Macroprep DEAE support (Bio-Rad)
and a NaCl gradient (0 to 1 M in 50 mM Tris-HCl). The pooled fractions were
assayed with an enterococcal patient serum using dot blots, dialyzed with dH2O,
and kept at 80°C. The pooled (prepurified) fractions were further purified at
the Complex Carbohydrate Research Center, University of Georgia, by Superose
6 size exclusion column (elution buffer, 10 mM ammonium formate [pH 5.0]) or
normal-phase chromatography. For normal-phase chromatography, polysaccha-
ride was loaded onto an Avicel PH101 microcrystalline cellulose column which
had been preequilibrated in 50% ethanol followed by elution with an ethanol
gradient (50 to 0%) buffered to pH 5.65 with triethylammonium acetate. A crude
extract of carbohydrates from TX5179 (epaB) was also sent to the Complex Carbo-
hydrate Research Center, where it was purified by Superose 6 size exclusion column.
Compositional and 31P-nuclear magnetic resonance analyses were performed by the
Complex Carbohydrate Research Center, University of Georgia.
Biofilm assay. Biofilm formation by OG1RF and derivatives was determined
as described previously with cells grown in TSBG (21). After 24 h of growth and
before being processed for biofilm formation, OD600 was determined (growth
OD). Biofilm formation was assessed at OD570 after processing and crystal violet
staining. The experiments were performed twice, and eight wells per strain were
used in each experiment. One-way analysis of variance with Bonferroni’s post
test was used to compare OG1RF and derivatives.
Phage infection assays. Phage NPV-1 stock (29) was prepared using E. faecalis
OG1RF. To compare the phage sensitivity of OG1RF and its derivatives, E.
faecalis strains were grown in BHI broth with appropriate antibiotics at 37°C
overnight. Cells were washed and resuspended in 10 mM MgSO4 (adjusted to an
OD550 of 1 for all strains). Ca. 100 NPV-1 phage (in a 100-l volume) were
mixed with 100 l of OD-adjusted bacterial cells and incubated at room tem-
perature for 20 min, followed by addition of 4 ml BHI soft agar (0.7%), and then
poured onto a BHI agar plate. Plaques were counted after overnight incubation
at 37°C. For the adsorption test, 100 l of bacterial cells (prepared as described
above) and 1,000 NPV-1 phage in a 100-l volume were mixed, the mixture was
centrifuged after 1, 5, or 10 min of incubation at room temperature, and the
supernatant was taken and the titer of phage was determined using OG1RF.
Electron microscopy. E. faecalis OG1RF and the orfde4 (epaB) mutant were
grown overnight in BHI broth at 37°C. In the first set of experiments, the cells
were processed directly for electron microscopy (3). In a second set of experi-
ments, 500 l of the cultures was collected and resuspended in 500 l of fresh
BHI broth, followed by mixing with phage NPV-1 (bacterium/phage ratio of 1:2).
After 10, 30, or 45 min of incubation at 37°C, the bacterial cells were collected,
resuspended in 500 l of 2.5% glutaradehyde, and incubated at room tempera-
ture for 20 min. After centrifugation, the cell pellets were kept at 4°C before
processing for electron microscopy (3). At least 10 different fields were exam-
ined, and representative fields were selected.
Mouse peritonitis model. In vivo testing was performed with the mouse peri-
tonitis model, and the 50% lethal dose and Kaplan-Meier survival curves were
determined and log rank analysis was performed as described previously (27).
RESULTS
Organization of the epa cluster and effect of disruption of
epa genes on growth and cell morphology. Based on the results
to be discussed below and on the OG1RF genome sequence
(4), the genes previously designated as “orfde3” to “orfde16”
(derived from the cosmid sequence) (31, 32) were renamed
here as “epaA” to “epaO” (Fig. 1A and Table 1). In addition,
three genes downstream of epaO are part of an operon with
epaLMNO (see below); thus, these three genes were desig-
nated “epaP,” “epaQ,” and “epaR,” the last one encoding a
sugar transferase. We also identified two short ORFs (epaJ and
epaK) between epaI (orfde10) and epaL (orfde11) that encode
hypothetical membrane proteins that were not identified in the
previously described cosmid clone of this region. Finally, epaM
corresponds to the area previously annotated in the cosmid as
“orfde12” and “orfde13” (forming the upstream and down-
stream portions of epaM) and epaN corresponds to the area
including both orfde14 and orfde15, bringing the total number
of known genes in the epa locus in OG1RF to 18 (Fig. 1A). An
updated annotation of those genes is included in Table 1. Dis-
ruption of orfde2, epaA, epaM, and epaN resulted in OG1RF
derivatives TX10113, TX10114, TX5391, and TX5436, respec-
tively. (All of the disruptions are illustrated in Fig. 1B and listed
in Table 2.) We confirmed the polar effect of our disruption
mutants on the downstream genes by qRT-PCR. Indeed, the
genes within each of the epaBCD, epaEFGHIJ, and epaLMNOPQ
loci were found to be cotranscribed (data not shown). In conclu-
sion, with the disruption of five genes, we affected the production
of 16 out of the 18 proteins encoded by the epa locus.
The epa mutants, the orfde2 mutant, and DAGF29 (trans-
poson insertion in OG1RF_0163) as well as OG1RF were
tested for growth and phenotype in BHI (routine broth), BHIS
(BHI–40% serum), and TSBG (biofilm medium). In TSBG,
three mutants (epaB, epaE, and epaN) grew as well as wild-type
OG1RF, while the epaA and epaM mutants showed slower
exponential growth phase (Fig. 1C) and did not reach the same
OD in the stationary phase as OG1RF. In BHIS, only the epaM
mutant was affected, with a lag phase 1 h longer than that of
the other strains (Fig. 1D). The epaB, epaE, and epaM mutants
presented growth patterns and survival rates in the stationary
phase comparable to those of wild-type OG1RF. Finally, in
BHI, the epaE and epaN mutants grew as well as OG1RF
during the exponential growth phase, while the epaB mutant
showed only a slightly lower OD600 in the stationary phase
(10%; P  0.0286) (data not shown). The epaA and epaM
mutants generated lower OD600s than wild-type OG1RF, with
a slower exponential growth phase and a lower survival rate in
the stationary phase (1 log lower CFU than OG1RF at 24 h;
P  0.05) (data not shown). However, if the data are corrected
for multiple comparisons, the significance disappears. The
orfde2 and DAFG29 mutants behaved like wild-type OG1RF
under all conditions tested.
By phase-contrast microscopy with cells grown overnight in
TH broth with 1.0% glucose, we observed oval cells present
mostly as diplococci for OG1RF and the orfde2 and DAGF29
mutants and round, mainly single cells (shorter than OG1RF
cells) for the epaA, epaB, epaE, epaM, and epaN mutants (Fig.
2A). Interestingly, the epaB mutant complemented with the
epaBCD-containing plasmid (where 229/238 amino acids [aa]
of EpaD should be translated) showed a mixed population with
oval and round cells, indicating that the truncated version of
EpaD may be partially functional or that the stoichiometry of
the enzymes/intermediaries in the pathways controlled by the
products of EpaB and EpaC was not fully restored. The dif-
ferent shapes of wild-type OG1RF and the epaB mutant were
further seen in electron microscopy (Fig. 2B).
Effect of disruption of epa genes on polysaccharide content.
Our initial comparison of the polysaccharide contents of
OG1RF and the epaB mutant showed three polysaccharide
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bands with OG1RF extracts (named PS1, PS2, and PS3) and
two polysaccharide bands (PS12 and PS3) for the epaB mutants
(Fig. 3A); PS12 was so named because it ran in a position
between PS1 and PS2 and was not present in OG1RF (Fig.
3A). We then compared the polysaccharide contents of all of
the mutants and found the following. (i) PS1 was completely
missing in the epaB, epaE, epaM, and epaN mutants (Fig. 3B,
lanes 4, 5, 6, and 7) and was reduced in the epaA mutant (Fig.
3B, lane 3), while PS1 production was restored in the epaB-
complemented strain (lane 8). (ii) Depending on the extracts,
a variable amount of PS2 (in some extracts, a very small
amount) was detected in wild-type OG1RF (lane 1) and the
epaB-complemented strain. (iii) The new polysaccharide band,
PS12, was seen in the epaA (in small amounts), epaB, epaE,
epaM, and epaN mutants and was also detected in residual
amounts in the epaB-complemented strain. (iv) The orfde2
mutant (lane 2) showed a polysaccharide pattern similar to
that of wild-type OG1RF (Fig. 3B).
Serum from a patient with E. faecalis endocarditis (S0013)
has previously been shown to react with polysaccharide ex-
tracts of wild-type OG1RF but not with those of the epaB and
the epaE mutants (26). In the present study, S0013 reacted with
polysaccharide extracts of wild-type OG1RF and the orfde2
and epaA mutants, while no reaction was detected for polysac-
charide extracts of the epaB, epaE, epaM, and epaN mutants.
The reactive pattern was restored for the epaB-complemented
strain (Fig. 3C).
Composition of OG1RF polysaccharides. Polysaccharides were
purified from OG1RF (grown in TH broth with 1% glucose
without shaking for 24 h at 37°C), and one purified fraction
reacted with S0031 and migrated the same distance in the gel as
PS1; thus, it was named “Epa” due to its absence in epa mutants
and its reaction with patient serum. Compositional analysis re-
vealed the presence of glucose, rhamnose, N-acetylglucosamine
(glcNAc), N-acetyl galactosamine (galNAc), and galactose in this
material. No phosphate was detected in this material. Rhamnose
FIG. 2. Morphology of OG1RF and the epaB mutant cells by phase-contrast microscopy (A) and thin-section electron microcopy (B).
Disruptions are denoted by an inverted triangle.
FIG. 3. Polysaccharides of OG1RF and its derivatives. (A and B)
Stains-All-stained polysaccharide extracts in 0.8% agarose gel;
(C) Western blots with polysaccharide extracts and patient serum.
Lane 1, OG1RF; lane 2, TX10113 (the orfde2 mutant); lane 3,
TX10114 (the epaA mutant); lane 4, TX5179 (the epaB mutant);
lane 5, TX5180 (the epaE mutant); lane 6, TX5391 (the epaM
mutant); lane 7, TX5436 (the epaN mutant); lane 8, TX5179.1 (the
epaB-complemented strain).
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was not found in the polysaccharide of the epaB mutant, but
instead mannose was present; glucose, galNAc, galactose, and
glcNAc were also found in the polysaccharide of the epaBmutant.
Both polysaccharides from OG1RF and the epaB mutant were
observed to have a molecular mass of31 kDa by size exclusion.
Effect of disruption of epa genes on biofilm formation. The
epaA, epaB, epaE, epaM, and epaN mutants showed significant
reduction in biofilm formation (OD570) compared to wild-type
OG1RF (at least 50%; P  0.001), while biofilm produced by
the orfde2 and DAGF29 mutants was comparable to that of
OG1RF (Fig. 4A and B). Interestingly, although the growth
ODs (OD600) of the epaA and epaM mutants under biofilm
conditions (static environment) were significantly lower (0.293
and 0.283, respectively; P  0.001, as in batch cultures) than
that of OG1RF (0.352), which may have contributed to their
lower biofilm OD, the growth OD600s of the epaB and epaE
mutants were significantly higher (0.419 and 0.409, respec-
tively; P  0.001) while still generating less biofilm. On the
other hand, the epaB-complemented strain showed a 1.5- to
2-fold increase in biofilm formation compared to the epaB
mutant (P  0.001), although not equal to that of wild-type
OG1RF (Fig. 4A). This result was expected since the epaB-
complemented strain is not fully restored, as seen by micros-
copy with the mixed-shape population.
Effect of disruption of epa genes on phage sensitivity. E.
faecalis OG1RF has previously been found to be sensitive to a
phage called NPV-1 (29). We had planned to use this phage to
eliminate extracellular E. faecalis wild-type OG1RF and mu-
tants for phagocytosis and intracellular survival studies, and so
we tested phage sensitivity of OG1RF and its derivatives. We
observed clear plaques when growing OG1RF with NPV-1.
However, testing for phage sensitivity with the epa mutants
showed that NPV-1 (1:2 dilution) did not form plaques with
the epaB, epaE, epaM, or epaN mutants, while reduction in
PFU was shown with the epaA mutant compared to wild-type
OG1RF (Fig. 5); some lysis was observed with undiluted
phage. The epaB-complemented strain produced slightly lower
PFU than wild-type OG1RF, and the orfde2 and DAGF29
mutants produced similar PFU to wild-type OG1RF (Fig. 5).
To determine whether the resistance of the epa mutants to
NPV-1 was due to deficiency in phage adsorption, wild-type
OG1RF and the epaA and the epaB mutants were compared,
and no significant difference was detected for these strains
(data not shown).
Electron microscopy of OG1RF and the epaB mutant grown
with NPV-1 phage showed that phage particles, with filled or
empty heads and a long tail, were attached to both wild-type
OG1RF and the epaB mutant cells after 10 min (Fig. 6A and
B). At 45 min, after looking at many fields under the micro-
scope, there was evidence of bacterial lysis by phage particles
with OG1RF cells, but not with the epaB mutant (Fig. 6C).
Effect of disruption of epa genes on virulence. Previously, we
have shown that disruptions in epaB (orfde4) and epaE (orfde6)
caused significant attenuation in the mouse peritonitis model
(33). In the present study, we examined the epaM and epaN
mutants in this model and found that the two strains were
significantly attenuated (Fig. 7) (P  0.0051 and 0.0051 by log
rank for the epaM and epaN mutants versus OG1RF, respec-
tively). Since epaM had a lower survival rate than OG1RF and
epaN in BHI broth once the culture reached the stationary
phase, the accuracy of the inocula was verified by CFU deter-
mination. The results presented in Fig. 7 were obtained after
inoculation of 3.5  108 cells of the epaM mutant versus 3.4 
108 cells of the OG1RF wild type and 3.4  108 cells of the
epaN mutant versus 3.4  108 cells of the OG1RF wild type.
DISCUSSION
Biosynthesis of polysaccharides generally involves synthesis
of nucleotide sugar precursors in the cytoplasm, formation and
polymerization of repeating units, and export to the cell sur-
face. The E. faecalis epa gene cluster contains genes encoding
enzymes and transporters potentially involved in all of these
processes. For example, the predicted EpaA protein shows
similarity to undecaprenyl-phosphate 	-N-acetylglucosaminyl-
transferase (a member of the glycosyl transferase group 4 fam-
ily), while the products of epaB, -C, -D, -I, -N, and -O and
OG1RF_0164 (4) show similarity to the glycosyl transferase
group 2 family. The predicted OG1RF_0163 (4) protein shows
similarity to glycosyl transferase group 25, the predicted prod-
uct of epaR is a sugar transferase, epaEFG and -H are similar
FIG. 4. Biofilm formation by OG1RF and its derivatives. (A)
TX10113, TX10114, TX5179, TX5180, TX5391, TX5436, and
TX5179.1 are the orfde2, epaA, epaB, epaE, epaM, and epaN mutants
and the epaB-complemented strain, respectively. (B) DAGF29 is the
OG1RF_0163 transposon insertion mutant (9).
FIG. 5. Phage sensitivity of OG1RF and its derivatives. NPV-1
phage was used to infect TX10113, TX10114, TX5179, TX5180,
TX5391, TX5436, and TX5179.1, which are the orfde2, epaA, epaB,
epaE, epaM, and epaN mutants and the epaB-complemented strain,
respectively. DAGF29 is the OG1RF_0163 transposon insertion mu-
tant (9). PFU are shown.
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to genes involved in dTDP-rhamnose biosynthesis pathway of
various organisms, and epaL and -M encode proteins with
similarity to components of ABC transport systems that might
be involved with exporting polysaccharide components (32).
To determine the limits of the epa genes of OG1RF, we
constructed disruption mutants and compared the polysaccha-
ride contents of the epaA, epaB, epaE, epaM, and epaN mutants
with that of wild-type OG1RF. Our results demonstrated that
the previously described genes orfde3 to -16 are important for
biosynthesis of Epa by OG1RF and, based on our observations,
we have renamed these genes “epaA” to “epaO,” while
EF2179, EF2178, and EF2177, cotranscribed with epaO, were
named “epaP,” “epaQ,” and “epaR.” In all, it appears that the
epa gene cluster is comprised of 18 genes flanked by orfde2 and
OG1RF_0164, with the expression of 16 of these 18 affected by
our disruptions in epaA, epaB, epaE, and epaN. A disruption
mutant of OG1RF_0163 behaved as OG1RF in the assays
tested (biofilm formation, phage sensitivity, and cell shape).
Similarly, neither orfde1 nor orfde2 is required for Epa produc-
tion, consistent with our previous observation that, in E. coli
with the cloned epa gene cluster, transposon insertions in
orfde1 and orfde2 did not affect polysaccharide antigen produc-
tion (32). At the same time, we found that disruption of the epa
genes (epaA, -B, -E, -M, and -N) resulted in a new polysaccha-
ride, possibly due to accumulation of some intermediary prod-
ucts resulting from loss of epa-encoded function(s). It is also
interesting to note that we were unsuccessful in obtaining an
epaO insertion mutant, although epaM and epaN insertion mu-
tants were obtained. One possibility is that an intermediary
substrate generated by epa genes is toxic to the cell in the
absence of one or several of the proteins encoded by
epaOPQR. Another possibility is that some epa-encoded func-
tions are complemented by other genes of OG1RF, allowing
mutants to be made, while others (e.g., one of the EpaOPQR
functions) are not. Such possibilities could also explain why
some mutants show a growth defect while others do not.
Compositional analysis of Epa (the band (PS1) from OG1RF
that reacted with E. faecalis patient serum and was not seen in
the epa mutants) showed rhamnose as one of its major sugar
residues. The carbohydrate compositional analysis of the epaB
mutant revealed replacement of rhamnose by mannose in
PS12, suggesting that the glycosyl transferases encoded by the
epaBCD operon contribute to rhamnose transfer to the poly-
saccharide. Since transcription of at least one glycosyl trans-
ferase was affected for each of the epaB, epaE, and epaM
mutants, in-frame deletion will be required to define the func-
tion of each of the six glycosyl transferases located in this epa
cluster. The predicted protein similarities and the lack of wild-
type Epa in the epaE, epaM, and epaN mutants suggest that
these genes may contribute to biosynthesis (epaE to -I) and
transport (epaL and -M) of rhamnose.
Although the PS1 and PS12 polysaccharides ran at different
positions in agarose gels, they showed similar molecular sizes
in a size exclusion column, suggesting different charges of these
FIG. 6. Electron microscopy of OG1RF and the epaB mutant in-
fected by NPV-1 phage. (A) Cell morphology in the presence of phage;
(B) attachment of phage (full head) to bacteria; (C) attachment of
phage (empty head) to bacteria. In panel D, OG1RF cells are filled
with phage particles and show early lysis, whereas no phage was seen
inside TX5179. The arrows point to the phage.
FIG. 7. Survival curves of OG1RF and its derivatives in the mouse
peritonitis model. Six mice per group were used, and P  0.0051 for
OG1RF versus TX5391 (the epaM mutant) or TX5436 (the epaN
mutant). The inocula for OG1RF, TX5391, and TX5436 were 3.4 
108, 3.5  108, and 3.4  108 CFU, respectively. Disruptions are
denoted by an inverted triangle.
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polysaccharides. Hsu et al. found previously that a surface-
located heteroglycan (20 kDa) isolated from clinical strains
of E. faecalis was composed of rhamnose, glucose, galactose,
mannosamine, and glucosamine (15). The similar composition
of the heteroglycan to our Epa polysaccharide (31 kDa)
suggests possible involvement of epa genes in biosynthesis of
this heteroglycan. Hancock et al. also reported similar compo-
sition of a cell wall polysaccharide isolated from E. faecalis,
strain FA2-2, although the molecular mass of that polysaccha-
ride was 50 kDa (13). The difference in sizes of these polysac-
charides may due to differences in methodology and/or differ-
ent strains used in the studies.
We also found that disruption of epa genes had an effect on
E. faecalis cell shape, producing more round cells. In addition,
disruptions of epaA and epaM appear to have an additional
effect on cell growth, but not disruption of epaB, epaE, and
epaN. Our study also found that the epa genes were important
for lytic infection of OG1RF by phage NPV-1. Although at-
tachment of this phage to the epa mutants was not obviously
affected, it was not clear whether the epa genes influence the
entry of the phage DNA into the mutant cells and/or influence
phage replication inside the mutant cells; thus, at the present
time, it is not clear how epa genes affect the NPV-1 lytic
infection cycle.
It was also interesting to find that the epaA mutant, unlike
other epa mutants, made a smaller amount of Epa and showed
an intermediate phenotype in phage infection: e.g., the epaA
mutant, when infected by the phage NPV-1, produced reduced
PFU versus wild-type OG1RF, while other epa mutants pro-
duced 0 PFU. These results suggest that the truncated EpaA
product (missing only the last 8 aa) in the epaA disruption
mutant has partial activity or that some function of EpaA may
be partially complemented by other factors in E. faecalis. We
previously found that in the E. coli recombinant clone with a
Tn7 insertion in the 3
 end of epaA, expression of the polysac-
charides was still detected, even in the rfe (E. coli homologue
of epaA) strain (32); this suggests the EpaA may not be needed
by E. coli to synthesize the polysaccharides or, again, that
truncated EpaA may be partially active. The intermediate phe-
notype of the epaA mutant was not seen in biofilm formation,
suggesting that EpaA functions differently in these processes.
Previously, we showed that the epa genes were present in 12
of 12 distinct E. faecalis strains by Southern blots with PCR
products of orfde4 to -10 (26), suggesting that Epa, unlike the
serotype-specific capsular polysaccharide, Cps (13), is a com-
mon component of E. faecalis. In the present study, we further
confirmed widespread distribution of epa genes in E. faecalis by
dot blot hybridization with 92 E. faecalis strains (data not
shown). Although the epa genes are widespread, genomic com-
parison indicates that differences occur in the epa gene cluster
and in the surrounding area. In OG1RF, a unique gene cluster
is present downstream of the epa gene cluster replacing
EF2166 to EF2176 present in V583 (4). This OG1RF unique
gene cluster predicts 14 proteins, 9 of which are likely associ-
ated with polysaccharide biosynthesis (4). In V583, a small
transposon carrying four genes (EF2185 to EF2188) is inserted
in the 74 bp between epaJ and epaK, leaving these two small
ORFs and their respective promoter areas intact. Preliminary
data indicate that neither the OG1RF unique gene cluster nor
the transposon detected in V583 is present in two other se-
quenced E. faecalis strains (personal observation).
Future studies to determine the localization of the Epa com-
ponents in the outer layers of E. faecalis, as well as the effect of
disruption of Epa on expression and/or localization of other E.
faecalis virulence factors, may provide insight into the pleiotro-
phic effect of Epa on translocation, biofilm formation, PMN-
mediated killing, and virulence. Such studies should also ad-
vance our understanding of the human response to E. faecalis
infection, which may potentially help the design of immuno-
therapeutic agents against E. faecalis infections.
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